Sage Journals: Discover world-class research

Open access

Case report

First published 2021

Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia

Nerea Báez-Gutiérrez, Héctor Rodríguez-Ramallo, María Antonia-Pérez Moreno [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2019

Management of myelodysplastic syndromes after failure of response to hypomethylating agents

Angela Gil-Perez, Guillermo Montalban-Bravo

Therapeutic Advances in Hematology

Open access

Brief report

First published 2025

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong

Qiwen Fang, Chi Yeung Fung, Jiaqi Wang [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2020

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents

Ka-Won Kang, Byung-Hyun Lee, Min Ji Jeon [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2024

Clinical activity,pharmacokinetics,and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review

Ryan Haumschild, Julie Kennerly-Shah, Lisa Barbarotta [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2025

Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents

Taylor Gabbard, Bernard L. Marini, Kamran M. Mirza [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Adding venetoclax or hypomethylating agents to induction chemotherapy as first-line treatment for adults with acute myeloid leukemia: a retrospective case-cohort study

Fangfei Xu, Kuangguo Zhou, Duanhao Gong [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2022

Relevance of infections on the outcomes of patients with myelodysplastic syndromes,chronic myelomonocytic leukemia,and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

Laura Vilorio-Marqués, Christelle Castañón Fernández, Elvira Mora [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2026

Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Amer M. Zeidan, Ruizhi Zhao, Jon G. Tepsick [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2022

Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents

Sridhar A Malkaram, Aymen Shatnawi, Jun Fan [...]

Cancer Control

Search results